Intervention Review

Drug treatment for myotonia

  1. Jeroen Trip1,*,
  2. Gea G Drost2,
  3. Baziel GM van Engelen3,
  4. C G Faber4

Editorial Group: Cochrane Neuromuscular Group

Published Online: 25 JAN 2006

Assessed as up-to-date: 29 JUL 2009

DOI: 10.1002/14651858.CD004762.pub2


How to Cite

Trip J, Drost GG, van Engelen BGM, Faber CG. Drug treatment for myotonia. Cochrane Database of Systematic Reviews 2006, Issue 1. Art. No.: CD004762. DOI: 10.1002/14651858.CD004762.pub2.

Author Information

  1. 1

    Diaconessenhuis Meppel, Neurologist, Meppel, Netherlands

  2. 2

    Radboud University Nijmegen Medical Center, Department of Neurophysiology, Nijmegen, Netherlands

  3. 3

    Radboud University Nijmegen Medical Center, Neuromuscular Center Nijmegen, Nijmegen, Netherlands

  4. 4

    MUML, Department Neurology, Maastricht, Netherlands

*Jeroen Trip, Neurologist, Diaconessenhuis Meppel, Hoogeveenseweg 38, Meppel, 7943 KA, Netherlands. jeroentrip1975@gmail.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 25 JAN 2006

SEARCH

Options for accessing this content:

  • If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
    http://wiley.force.com/Interface/ContactJournalCustomerServices_V2.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.